• Latest Posts

Roche and Alnylam to work on RNAi therapeutic to treat hypertension

Partnership between Paradigm4 and Alnylam accelerates drug target discovery

In Depth 22 Jul 2022

The coming of age story of RNAi technology

In Depth 4 Jul 2022

The COVID-19 pandemic has driven RNA therapeutics into the mainstream

Alnylam Gets Second RNAi Drug Approval from EMA

Novartis Enters RNA Therapeutics with Medicines Company Merger


UK Biotech Settles Lawsuit on the First RNAi Drug

In Depth 19 Sep 2017

RNA as a Therapy: Reviewing the Future Generation of Therapeutics

Sanofi and US Partner Launch Phase III Trial in Hemophilia with RNAi

RNAi Therapy is Back: Sanofi is firmly on board to treat Hemophilia